Association between serum potassium levels and peritonitis in peritoneal dialysis patients: a longitudinal study

Tang Wk, Shaojie Zhang, Wanyu Yang, Lichun Hong, Lin Jiang, Xinyue Su, Junli Jin, Qijing Zhang, Xun Tang, Tingting Guo, Zirui Chen, Qi Ye, Yujing Zhou, Xiang Lv, Yu Zhang, Jun ZhangBMC 2026 · DOI

TL;DR

This study reveals that while initial serum potassium levels don't predict peritonitis in peritoneal dialysis (PD) patients, a rapid decline and persistently low levels over time significantly increase the risk. This highlights the critical need for dynamic monitoring of potassium and intensified management, particularly around the four-year mark of PD treatment, to mitigate peritonitis incidence.

What Problem Does This Paper Address?

Peritoneal dialysis (PD) is a vital treatment for end-stage renal disease, but it's prone to complications, most notably peritonitis. While hypokalemia (low serum potassium) has been implicated as a risk factor for peritonitis, most previous research has been cross-sectional, offering only a snapshot in time. This leaves a critical gap in understanding how the dynamic changes in serum potassium levels over the course of PD treatment influence peritonitis risk. The paper aims to fill this gap by longitudinally analyzing serum potassium trends and their association with peritonitis in a large cohort of PD patients.

Methods

The researchers employed a retrospective observational design, analyzing data from 1,288 PD patients. To investigate the association between baseline characteristics and peritonitis, they used Cox proportional hazards models. For analyzing the longitudinal changes in serum potassium and other lab markers in relation to peritonitis, a mixed-effects model was utilized. The time to peritonitis was estimated using Kaplan-Meier survival analysis. To explore differences in serum potassium based on the type of bacteria causing peritonitis, an independent samples t-test was applied. Finally, the correlation between serum potassium and magnesium was assessed using Spearman correlation analysis and visualized with scatter plots. The trend of peritonitis incidence over time was analyzed using the Cochran-Armitage trend test.

Datasets

The study utilized a dataset of 1,288 PD patients from the Nephrology Department of Zhujiang Hospital of Southern Medical University, collected between March 22, 2010, and January 1, 2024. This dataset included baseline demographic information, comorbid conditions, and longitudinal laboratory test results from hospital admissions.

Key Insights and Ideas

  • It's not just low, it's the trend that matters: The study strongly suggests that the rate of decline and sustained low levels of serum potassium are more predictive of peritonitis than a single low measurement. This shifts the focus from static snapshots to dynamic patient monitoring.
  • The "sweet spot" for monitoring: The median time to peritonitis was found to be around 4.09 years. This suggests that the period around the 4-year mark of PD treatment might be a critical window for intensified monitoring and intervention.
  • Peritonitis incidence is decreasing: The study observed a significant linear downward trend in PDAP incidence from 2011 to 2023, likely due to advancements in PD technology, improved management guidelines, and better patient education.
  • Potassium and Magnesium: A weak but significant link: While the correlation between serum potassium and magnesium was weak, it was statistically significant. This hints at a potential interconnectedness in electrolyte management that warrants further investigation.

Key Results

  • Baseline predictors of peritonitis: Higher baseline lymphocyte count and female gender were associated with a lower risk of peritonitis, while older age and higher baseline uric acid levels were linked to a higher risk.
  • Longitudinal potassium trends: Patients who developed peritonitis showed a more rapid decline in serum potassium levels and maintained lower levels for longer periods compared to the non-peritonitis group.
  • Median time to peritonitis: The Kaplan-Meier analysis estimated the median time to peritonitis to be 4.09 years.
  • Bacterial pathogen analysis: No significant difference in serum potassium levels was found between patients infected with Gram-positive cocci (GPC) and Gram-negative bacilli (GNB).
  • Potassium-Magnesium correlation: A very weak positive correlation (r=0.111, P<0.01) was observed between serum potassium and magnesium.
  • Annual PDAP incidence trend: A significant linear downward trend in PDAP incidence was observed from 2011 to 2023, with a 47.6% decrease from 2011 to 2023.

Limitations and Future Work

The authors acknowledge that this was a single-center retrospective study. They also note that dietary factors, specific medications, and other potential influencing factors were not included in the analysis, which could have impacted the results. Future work could involve larger, multi-center studies that incorporate these additional variables. The study also suggests that further investigation into the interconnectedness of potassium and magnesium, and the development of targeted interventions based on dynamic monitoring, are crucial for improving PD patient outcomes.

Summary updated

Abstract

Abstract Background Abnormal serum potassium levels are common among peritoneal dialysis (PD) patients. Many studies have shown hypokalemia as a risk factor for peritonitis, but most were cross-sectional and observational. We intended to analyze the longitudinal association between serum potassium levels and peritonitis in those undergoing PD. Methods We included 1,288 patients undergoing regular PD at our institution. The endpoint event was peritonitis. Patients were divided into peritonitis and non-peritonitis groups. The relationship between baseline data and the emergence of peritonitis was analyzed through Cox regression analysis. Mixed-effects model was used to analyze the correlation between longitudinal serum potassium and other lab characteristics with peritonitis. Kaplan-Meier survival analysis estimated the median time to peritonitis.Independent samples t-test was used in subgroup analysis to explore the relationship between serum potassium and different pathogenic bacteria. Spearman correlation analysis and scatter plot were used to evaluate the correlation between serum potassium and magnesium. Cochran-Armitage trend chi-square test assessed the trend of peritonitis incidence. Results COX regression analysis found higher baseline lymphocyte count and female gender were associated with lower peritonitis risk, while older age and higher baseline uric acid levels were linked to higher risk. A mixed-effects model indicated that the peritonitis group’s serum potassium decreased more rapidly and remained low longer. Kaplan-Meier curves estimated the median time to peritonitis to be 4.09 years. The analysis of subgroups found no significant difference in serum potassium levels between the gram-positive and gram-negative bacteria groups. Spearman correlation analysis showed a very weak positive correlation between potassium and magnesium with poor trend consistency but statistical significance. Peritonitis incidence showed a significant linear downward trend from 2011 to 2023. Conclusions Rapid declines and long-term low levels of serum potassium after PD initiation increase peritonitis risk. Long-term potassium management in PD patients is crucial in clinic practice, with intensified monitoring advised around 4 years into PD treatment. Trial registration 2023BA0125_GC; 2023-10-20.
BibTeX
@inproceedings{wk2026association,
  author = {Tang Wk and Shaojie Zhang and Wanyu Yang and Lichun Hong and Lin Jiang and Xinyue Su and Junli Jin and Qijing Zhang and Xun Tang and Tingting Guo and Zirui Chen and Qi Ye and Yujing Zhou and Xiang Lv and Yu Zhang and Jun Zhang},
  title = {{Association between serum potassium levels and peritonitis in peritoneal dialysis patients: a longitudinal study}},
  booktitle = {BMC},
  year = {2026},
  doi = {10.1186/s12882-025-04690-3},
}
Figure